Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker BNTC
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | BNTC Benitec Biopharma Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 13, 2026 | BNTC Benitec Biopharma Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 28, 2026 | BNTC Benitec Biopharma Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 5, 2026 | BNTC Benitec Biopharma Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 30, 2026 | BNTC Benitec Biopharma Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Sep 24, 2026 | BNTC Benitec Biopharma Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Sep 14, 2026 | BNTC Benitec Biopharma Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 29, 2026 | BNTC Benitec Biopharma Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 14, 2026 | BNTC Benitec Biopharma Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 12, 2026 | BNTC Benitec Biopharma Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 2, 2025 | BNTC Benitec Biopharma Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Nov 14, 2025 | BNTC Benitec Biopharma Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 7, 2025 | BNTC Benitec Biopharma Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 7, 2025 | BNTC Benitec Biopharma Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 3, 2025 | BNTC Benitec Biopharma Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 3, 2025 | BNTC Benitec Biopharma Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 3, 2025 | BNTC Benitec Biopharma Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 22, 2025 | BNTC Benitec Biopharma Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 12, 2025 | BNTC Benitec Biopharma Inc. | 4.02 Non-Reliance on Previously Issued Financial Statements | 8-K | 8-K ↗ |
| Jul 9, 2025 | BNTC Benitec Biopharma Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 14, 2025 | BNTC Benitec Biopharma Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 28, 2025 | BNTC Benitec Biopharma Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 27, 2025 | BNTC Benitec Biopharma Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 26, 2025 | BNTC Benitec Biopharma Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 26, 2025 | BNTC Benitec Biopharma Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 20, 2025 | BNTC Benitec Biopharma Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 19, 2025 | BNTC Benitec Biopharma Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 14, 2025 | BNTC Benitec Biopharma Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 31, 2024 | BNTC Benitec Biopharma Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Dec 13, 2024 | BNTC Benitec Biopharma Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 10, 2024 | BNTC Benitec Biopharma Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Dec 10, 2024 | BNTC Benitec Biopharma Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Dec 6, 2024 | BNTC Benitec Biopharma Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Nov 14, 2024 | BNTC Benitec Biopharma Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 14, 2024 | BNTC Benitec Biopharma Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
35 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:37 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances